chrisvoncsefalvay/vaers-outcomes huggingface dataset:
20 minutes after administration part of the face became numb, I had involuntary movements in part of a facial muscle and then the whole face became numb.
Started with mild numbing/tingling in left hand palm about few days or may be a week after the vaccine shot. Over the period of next few months the intensity of tingling increased and spread across the length of left arm and then on to left leg. Currently, both left arm and legs (lower calf/shin and extending onto toes)  have tingling though out the day. It becomes worse when sitting for long periods.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication were reported. No treatment medication were reported.   This case was linked to MOD-2021-395985 (Patient Link).
Left swelling (+) erythema (+) warmth.  Treated for cellulitis.
Patient became unconscious shortly after administration of HPV9 vaccine. Patient was sitting on exam table and was lowered down onto the table by the Medical Assistant.
This non-serious initial spontaneous case, was received on 26-Nov-2017, from the other health care professional, concerning an elderly male patient (reported as age 65+). On an unspecified date (6-10 years ago), the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported) at work place. On an unspecified date, after vaccination, the patient had fever, coughing, runny nose and dizziness. The reporter assessed the events as related.
On 8/30/01, the pt had Hep-B #1. On 9/6/01, the pt developed diffuse rash over her body. It resolved with Zyrtec. On 12/13/01, the pt had a 2nd Hep-B and developed a rash later, that itched.
Patient experienced excessive sweating and light headedness approximately 2 minutes following his vaccination. Management was called. Patient was instructed to lean towards knees incase  of fainting. Patient was given water and EMT responded. When offered to be assessed by EMT, patient responded that he was feeling better. Patient was observed for 30 minutes following vaccine and stated he felt fine before leaving.
I received the Moderna Bivalent booster for COVID-19 on 9/13/2022. On 11/21/2022, I developed a cough. On 11/22/2022, I took a home antigen test and got a positive result. I isolated. The only symptom I had was the cough. It did not worsen. Instead, it went away after about 2 days. On 11/23/2022, I spoke to my doctor, who prescribed Paxlovid. Even though my symptoms vanished quickly, I took the full course of Paxlovid. I was asymptomatic after the cough went away, but I continued to test positive until 11/29/2022. On 12/8/2022, I tested positive again. I was asymptomatic, though. I have continued to test regularly ever since. On the night of 12/13/2022, I developed a bit of a runny nose. When I tested myself on the morning of 12/14/2022, I still got a positive result. At the time of this writing, I still have a bit of a runny nose, but it's not as runny as it was on 12/13/2022.
10 days after the Moderna  1st shot I developed a red rash on the arm that received the shot, just above the injection site. About the diameter of a tennis ball. Very red, warm to touch, moderately itchy. Because it was so long after the shot, and because I found nothing in the information about side effects, I was not sure it was connected. It disappeared after a few days ( I did take Benadryl twice).  On 2-1-2021, I had the second shot of Moderna in the same arm. (Lot number 042L20A). On Feb 3rd I began to devolve the same type of rash, again on the arm the injection was on. By happenstance, someone else mentioned a similar side effect, and said it was mentioned in on line information. I checked and saw that there was a post about an arm rash on some recipients, but that few had been reported, so I decided I should go ahead and report. The rash is still with me(note only been a day since developed) but it is not severe and I am not particularly concerned about it. I?m going to answer yes on item 20 because the original rah resolved.
Light-headedness; slight nausea; Slight arm-ache around the vaccine shot spot; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 23-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 17Apr2021 16:45 (Lot number: ER8737) at the age of 23 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Glucose-6-phosphate dehydrogenase deficiency" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 17Apr2021, outcome "recovered" (18Apr2021), described as "Light-headedness"; NAUSEA (non-serious) with onset 17Apr2021, outcome "recovered" (18Apr2021), described as "slight nausea"; VACCINATION SITE PAIN (non-serious) with onset 17Apr2021, outcome "recovered" (18Apr2021), described as "Slight arm-ache around the vaccine shot spot". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, nausea, vaccination site pain.  No follow-up attempts are possible. No further information is expected.
Started with myalgias the evening (Tuesday) after vaccine. There was more pain than what I expected at the injection site. The following day (Wednesday) myalgias worsened, fever began reaching 101.9, chills and sensitive skin. The following day (Thursday) the fever peaked at 103.9 upon awakening,  falling to 102.1 that evening. Systemic symptoms (generalized myalgia) were slightly worse. Injection site pain was worse to the point it is difficult to raise my arm up to the side. Tenderness is present to the back of my shoulder and 6 inches from the injection site in the mid deltoid down my upper lateral and posterior upper arm. This AM (Friday) AM temp was 101.1 and is now down to 99.7. Myalgias have pretty much resolved. Extreme glycemic excursion occurred resulting in use of 50% more insulin to result in rather poorly controlled blood sugar for the event.
02/28/2021 9:30PM onset of fever 99.8-102F lasting to morning of 03/01/2021, onset of numbness in the oral cavity with numbness and swelling of the tongue on until end of 03/02/2021, onset of pain in the left deltoid injection site with traveling pain and numbness to left fingers 03/01/2021 until 03/02/2021. On 03/03/2021 symptoms are resolved.
vial was initially stored in the fridge on 16-Jan-2023, vaccine administered on 21-FEB-2023; No adverse event; they accidentally gave a bivalent booster dose which was 5 days beyond the BUD to a patient today; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (they accidentally gave a bivalent booster dose which was 5 days beyond the BUD to a patient today), PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 16-Jan-2023, vaccine administered on 21-FEB-2023) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 022H221) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: ATORVAGEN [ATORVASTATIN] (no longer taking) in May 2022 and ALMACOR [AMLODIPINE] (no longer taking) in May 2022. Past adverse reactions to the above products included No adverse event with ALMACOR [AMLODIPINE] and ATORVAGEN [ATORVASTATIN]. Concurrent medical conditions included Hypothyroidism (On Hydrochlorothiazide and levothyroxine for hypothyroid.). Concomitant products included HYDROCHLOROTHIAZIDE and LEVOTHYROXINE for Hypothyroidism.    On 21-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 21-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (they accidentally gave a bivalent booster dose which was 5 days beyond the BUD to a patient today). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 16-Jan-2023, vaccine administered on 21-FEB-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (they accidentally gave a bivalent booster dose which was 5 days beyond the BUD to a patient today), PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 16-Jan-2023, vaccine administered on 21-FEB-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (they accidentally gave a bivalent booster dose which was 5 days beyond the BUD to a patient today) and PRODUCT STORAGE ERROR (vial was initially stored in the fridge on 16-Jan-2023, vaccine administered on 21-FEB-2023).    Pharmacist called to report that they accidentally gave a bivalent booster dose which was 5 days beyond the BUD to a patient. The date the vial was initially stored in the fridge was on 16-Jan-2023.  Pharmacist called an hour after the administration and patient had not reported any adverse event.  No treatment drug was reported.
Simple febrile seizure 9 days after MMR and Varivax.  Seen in ER-felt to have simple febrile seizure 2 hours to MMR or viral syndrome.  Treated and released.  Pt seen in office 3 days later.  Had mild viral upper respiratory infection, no fever.
Shortness of Breath, cold chills, Tired, and dried mouth later the day of receiving the vaccine and next day.
Extreme sore arm, sore throat, extreme muscles pain, dizziness,  fatigue, swollen lymph nodes in left side of neck.
Pharmacist reports that 12 people have failed to respond to initial series of engerix-B vax in recent program;
Nasal swab PCR positive for SARSCoV2; Nasal swab PCR positive for SARSCoV2; This is a spontaneous report received from contactable reporter(s) (Other HCP).  A 24 year-old male patient received bnt162b2 (BNT162B2), administration date 10Apr2021 (Batch/Lot number: unknown) as dose 2, single and administration date 20Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant) all with onset 17Dec2021, outcome "unknown" and all described as "Nasal swab PCR positive for SARSCoV2"; COVID-19 PNEUMONIA (hospitalization, medically significant) with onset 17Dec2021, outcome "unknown", described as The events "nasal swab pcr positive for sarscov2", "nasal swab pcr positive for sarscov2", "covid19 lung infection", "fever" and "dry cough" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram thorax: (17Dec2021) groundglass opacities, notes: Groundglass opacities consistent with COVID19 lung infection; haemoglobin: (17Dec2021) 13.2; neutrophil count: (17Dec2021) 5.41; platelet count: (17Dec2021) 93; pyrexia: (17Dec2021) 101.8 Fahrenheit; sars-cov-2 test: (17Dec2021) positive; white blood cell count: (17Dec2021) 6.0. Therapeutic measures were taken as a result of covid-19 pneumonia, pyrexia, cough. The patient presented to ER on 17Dec2021 with complaint of fever (Tmax=101.8F) associated with dry cough. Nasal swab PCR positive for SARSCoV2.Chest CT in ER showed ground glass opacities consistent with COVID19 lung infection. Patient admitted and started empirically on IV cefepime and linezolid. Patient was vaccinated against SARSCoV2 bust has not received booster (inoculations administered 20Mar2021 and 10Apr2021). The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the vaccination failure  (LOE) cannot be ruled out.
DIFFICULTY BREATHING/SHORTNESS OF BREATH; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and  expiry: 01-APR-2021) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced difficulty breathing/shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and difficulty breathing/shortness of breath was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
1 of 2 adults pts vaxed from the same vial exp a 15cm area of swelling, redness & induration (size of half dollar); swelling extended from deltoid to elbow; resolved w/in 72 hrs; treatment included; warm soaks; afebrile; no cultures taken;
muscle pain in my left leg  for the last three days unable to sit or use my leg to stand up pain meds do not work
Client c/o  hot flashes on and off; tingling sensation L finger;  slight difficulty of breathing; slight dizziness and states " feels like having anxiety."
vomiting; feeling generally miserable; This case was reported by a other health professional via call center representative and described the occurrence of vomiting in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vomiting (serious criteria other: serious per reporter) and feeling miserable (serious criteria other: serious per reporter). On an unknown date, the outcome of the vomiting and feeling miserable were unknown.   It was unknown if the reporter considered the vomiting and feeling miserable to be related to Shingrix.  Additional details were provide as follows: This case was reported by the retired respiratory therapist. The age at vaccination was not reported. At another gathering of reporter's group another member stated that, she had reaction was one of vomiting and feeling generally miserable. The reporter consented to follow up. This case has been linked with case US2019083226, reported by the same reporter.
4 month old patient was given Hepatitis A pediatric dose instead of Hepatitis B vaccine.
pt recvd 2nd dose of vax on 4AUG92 & exp gen malaise, low grade fever, weakness, nausea, loss of appetite & elevated liver enzymes;
Patient woke Tuesday, 4 days after her second dose of Pfizer, and had terrible arm and back pain and what felt like really bad heart burn in her chest.  Her mother called Wednesday and told me about her symptoms and I suggested getting to a doctor and getting an EKG.  The patient came in today and was feeling much better but she was getting nitrogylcerin SL tabs and baby aspirin because cardiologist said she had  minor heart attack.
Patient experienced fever, tachycardia and dehydration in the evening following vaccination at 9:52 am. She was seen at ED and treated with IVF, had labs drawn and an xray performed. Seen in office 7/31/17 with symptoms of fatigue, stiff neck and headache. Treated with rest, stretching/massage and ibuprofen prn.
Cellulitis VS reaction to vaccine. Erythema from left elbow to shoulder, warm, mild swelling - 7 1/2" L x 8" w.
I had allergies and astmha about a month ago contributing factors were smoke inhalation and pollen humidity and mold cigarette smoke while on vaction.  07MAY2023 I had a sore throat and tightness in my chest loosing my voice  on10MAY2023 I began to get a fever and thenI called my Doctor and saw him on 12MAY2023 Bronchitis was diagnosed and Doxycycline was prescribed.
This spontaneous report was received from a pharmacist via company representative regarding a female patient of unknown age. No medical history and concurrent conditions were reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (lot number and expiry date unknown) to prevent shingles. Concomitant medications were not reported. On an unknown date, the patient developed an unspecified rash that "resembled shingles" at the injection site which travelled down to the unspecified arm. It was not known if the patient sought medical attention or received treatment. The outcome of the events was unknown. No product quality complaint was reported. Causality assessment was not provided. This is one of the two report from the same source. Additional information has been requested.
pt recvd vax & exp feverish feeling & sweats; next 2 days pt was sweating & pale; the next 3 days (14AUG93 through 17AUG93) exp h/a, heavy legs & aching back muscles; 17AUG93 slept a lot & was still sweating;
Intense pain in left wrist (same arm as vaccine administered).  After five months pain is close to being gone.  Light pain left hip.  Only noticeable when lying down.  Pain almost gone.
Patient complained of tingling tongue after 20 mins of observation BP: 100/60 R:20. Two 25 mg benedryl was orally given. Symptoms resolved after 5 minutes.
two 1/2 oblong patches of skin sloughed off inside bottom lip; two 1/2 oblong patches of skin sloughed off inside bottom lip; both hands swelled; total numbness; total loss of strength; knuckles red and swollen; severe itching both arms and lower back w/rash and swollen round areas; severe muscle pain; This is a spontaneous report from a contactable consumer (Patient).   A 72-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot number: EW0187), dose 2 via an unspecified route of administration, administered in left arm on 24May2021 at 11:00 (at the age of 72-year-old) as DOSE 2, SINGLE for COVID-19 immunization. Medical history included mitral regurgitation, collagenous colitis, atherosclerotic, high blood pressure. Concomitant medications included lisinopril taken for blood Pressure high, venlafaxine taken for depression, budesonide taken for shortness of breath and amoxicillin taken for an unspecified indication; start and stop date were not reported for all medications. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot number: ER8735), via an unspecified route of administration, administered in right arm on 03May2021 at 10:45 as DOSE 1, SINGLE for COVID-19 immunization. On 25May2021, the patient experienced severe muscle pain, on 26May2021, she experienced severe itching both arms, lower back w/rash and swollen round areas and on 27May2021, she experienced two 1/2 oblong patches of skin sloughed off inside bottom lip, (lose track of time) both hands swelled, total numbness, total loss of strength, knuckles red and swollen (then just left hand then just right hand and now on 10Jun2021 in right hand). As per reporter on 24May2021, she experienced none, 25May2021 awoke with severe muscle pain, 26May2021 ,27 May2021, and 28 May2021 severe itching both arms and lower back w/rash and swollen round areas, 27May2021 two 1/2 oblong patches of skin sloughed off inside bottom lip, (lose track of time) both hands swelled, total numbness, total loss of strength, knuckles red and swollen. then just left hand then just right hand, now 10Jun2021 right hand. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. No treatment was received in response to the adverse events. The outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
As soon as shot was given my heart began to pump  super hard and my lips, tongue, and throat began to swell. EpiPen was available but not used although as a hind sight it should have. Thankfully my throat didn't swell to the point where I couldn't breath but I did have to gasp for air a few times. After 30 minutes swelling begin to go down so I was told to go home and take Benadryl.
It was reported that a 2 year old female pt received Imovax Rabies, lot number not reported, administered IM in the deltoid on 3/29/04, as part of a post-exposure series after being bitten by a dog. Within 30 minutes to one hour after being discharged from the ER, the pt experienced weakness, an unspecified "color change" and was shaky. She returned to the ER and was treated with epinephrine and IV fluids (normal saline solution). She was admitted to the hospital; however, no further details were provided. The pt's recovery status was not reported. It was not reported whether the dog had been tested for rabies. A telephone call was placed to the reporting physician on 4/2/04 for the purpose of obtaining additional info. He stated that the pt was bitten by a stray dog and the animal was not captured or tested for rabies. The pt was seen in the ER and was administered a first dose of Imovax Rabies on 3/29/04. The physician did not have the lot number at the time of the telephone call, but stated that he would attempt to obtain it. He also stated that the pt did not receive RIG on 3/29/04 since the hospital did not have any available at that time. The pt received RIG the following day, on 3/30/04. The pt was admitted to the hospital on 3/29/04 and released on 3/31/04. It was not known if she recovered from these events.
booster doses administered after expiration date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date). On 19-Nov-2021, EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Booster dose was administered in deltoid muscle. No concomitant medications was provided by the reporter. No treatment was provided by the reporter.   This case was linked to MOD-2021-400510 (Patient Link).